APOA1 and neoplasm: When formulated with porphyrin-lipid, HDL-nanomimetics can thus exhibit multidimensional tumor targeting via apoA-I/SR-BI interactions, site-specific laser irradiation, and the inherent cancer cell affinity displayed by porphyrins (Zheng et al., 2007).